FDA Adverse Event Injury Summary report: N

GYNECARE GYNEMESH* PS

MDR report key: 2991577 · Received March 6, 2013

Report

Report Number
2210968-2013-02139
Event Type
Injury
Date Received
March 6, 2013
Report Date
February 11, 2013
Manufacturer
ETHICON, INC.
Product Code
OTO
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). URINARY/BOWEL PROBLEMS; NEUROMUSCULAR PROBLEMS. ADDITIONAL NARRATIVE: IT WAS REPORTED THAT MESH WAS IMPLANTED ON (B)(6) 2009 DUE TO PELVIC FLOOR REPAIR. FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, INFECTION, URINARY/BOWEL PROBLEMS, FISTULAE, NEUROMUSCULAR PROBLEMS AND VAGINAL SCARRING. NO ADDITIONAL INFORMATION WAS PROVIDED.

Additional Manufacturer Narrative · 1

IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED CONCURRENTLY WITH LAPAROSCOPIC ENTEROLYSIS, LAPAROSCOPIC COLPOPEXY, CYSTOSCOPY, POSTERIOR COLPORRHAPHY, AND PERINEORRHAPHY.

Additional Manufacturer Narrative · 1

(B)(4). SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2009 AND MESH AND SOLYX SIS SYSTEM WERE USED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
94791 GYNECARE GYNEMESH* PS MESH, SURGICAL, POLYMERIC OTO ETHICON, INC. NA BKP188

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention SOLYX SIS SYSTEM| SOLYX SIS SYSTEM